QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
City of Industry, CA -- (SBWIRE) -- 08/22/2018 -- This report studies the Prostate Cancer Diagnostics market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Prostate Cancer Diagnostics market by product type and applications/end industries.
In the last several years, global market of Prostate Cancer Diagnostics developed rapidly, with an average growth rate of 7.7%. In 2017, global revenue of Prostate Cancer Diagnostics is nearly 10 billion USD.
The global average gross margin of Prostate Cancer Diagnostics is in the decreasing trend, from 73.15% in 2013 to 71.65% in 2017. With the situation of global economy and technology, gross margin will be in decreasing trend in the following five years.
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Tumor Biomarker Tests in 2017 is about 59.6%.
Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 69% in 2017.
The major players in global Prostate Cancer Diagnostics market include
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/92cc731ed1a0849c4217e4ee9a876008,0,1
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Prostate Cancer Diagnostics in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
South America
RoW
On the basis of product, the Prostate Cancer Diagnostics market is primarily split into
Tumor Biomarker Tests
Imaging
Biopsy
Other
On the basis on the end users/applications, this report covers
< 55
55-75
> 75
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/149995/global-prostate-cancer-diagnostics-market
About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.